Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Kallithea – page 2

22 clinical trials in Kallithea, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kallithea at a glance
22
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Kallithea

Open in trial search
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:PF-07868489
  • Sponsor:Pfizer Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Sotatercept
  • Sponsor:Acceleron Pharma Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Sotatercept
  • Sponsor:Acceleron Pharma Inc.
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Aerovate Therapeutics Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Aerovate Therapeutics Inc.
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ralinepag
  • Sponsor:United Therapeutics Corp.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Seralutinib
  • Sponsor:GB002 Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ralinepag
  • Sponsor:United Therapeutics Corp.
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Seralutinib
  • Sponsor:GB002 Inc.

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Kallithea

What the registry says about research in the country

01 Pulmonary Arterial Hypertension Research

Multiple clinical trials focusing on innovative treatments for Pulmonary Arterial Hypertension (PAH), including evaluation of new medications like seralutinib and ralinepag. Studies aim to assess long-term safety and effectiveness of various therapeutic approaches.

  • Inhaled treatments assessment
  • Long-term safety studies
  • Exercise capacity improvement

Research includes both oral and inhaled medication delivery methods to optimize patient outcomes.

02 Cardiac Structure Studies

Investigations centered on Hypertrophic Cardiomyopathy, examining innovative treatments' effects on heart structure and function. Studies evaluate medications like mavacamten and aficamten for both obstructive and non-obstructive forms.

  • Cardiac imaging analysis
  • Symptom management
  • Exercise capacity evaluation

Research focuses on improving patient health status and cardiac structural modifications.

03 Cardiovascular Prevention

Clinical research examining preventive treatments for Atrial Fibrillation and related cardiovascular conditions. Studies evaluate new anticoagulation approaches and disease progression markers.

  • Stroke prevention
  • Systemic embolism prevention
  • Comparative treatment studies

Trials aim to advance therapeutic options for preventing cardioembolic events.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.